Skip to main content
ADIM logo

ADIM — Investor Relations & Filings

Ticker · 4142 ISIN · TW0004142005 LEI · 549300M5TV8YGVXU1827 TW Manufacturing
Open in API
Filings indexed 1,804 across all filing types
Latest filing 2018-05-10 Share Issue/Capital Cha…
Country TW Taiwan
Listing TW 4142

About ADIM

http://www.adimmune.com.tw/

ADIMMUNE CORPORATION, established in 1965, specializes in the research, development, and large-scale manufacturing of human vaccines and biologics. The company is a primary supplier of seasonal influenza and tetanus vaccines, maintaining production facilities that adhere to PIC/S GMP, US FDA, and EU standards. Its operations encompass the full product lifecycle, from initial R&D to commercial distribution. In addition to its proprietary vaccine portfolio, the company provides Contract Development and Manufacturing Organization (CDMO) services, supporting collaborative development and global supply chains. Recognized for its technical expertise in viral and bacterial vaccine production, the organization focuses on delivering high-quality immunization solutions to international markets while leveraging its history as a pioneering vaccine laboratory.

Recent filings

Filing Released Lang Actions
107年5月變更登記
Share Issue/Capital Change Classification · 95% confidence The document is a brief disclosure from a listed company (國光生) providing details about its capital stock, including authorized capital, paid-in capital, and changes such as capital reduction and cancellation of treasury shares. The document is very short (821 characters) and contains no financial statements or detailed analysis. It is essentially a regulatory announcement about capital changes rather than a full report or detailed financial filing. Therefore, it fits best under Share Issue/Capital Change (SHA) category, which covers announcements regarding new share issues, stock splits, or other capital changes.
2018-05-10 Chinese
公告本公司辦理註銷庫藏股減資變更登記完成
Share Issue/Capital Change Classification · 95% confidence The document is a short announcement (931 characters) about the completion of a capital reduction registration due to cancellation of treasury shares by the company 國光生. It includes details such as approval dates, changes in paid-in capital, shares issued, and net asset value per share. There is no detailed financial report or comprehensive analysis, only a regulatory announcement of a capital change event. According to the classification rules, announcements about capital changes such as share cancellations and capital reduction fall under Share Issue/Capital Change (SHA). The document is not a full financial report, nor is it a report publication announcement or certification. Therefore, the appropriate classification is SHA with high confidence.
2018-05-09 Chinese
107年04月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, general managers, and their related parties. It shows changes in shareholdings, types of shares held, and other related insider share transaction data. There is no indication of financial statements, earnings data, or management discussion. The content is focused on insider share transactions and holdings disclosures. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is substantial and contains actual data, not just an announcement or certification. Therefore, the appropriate classification is DIRS.
2018-05-08 Chinese
107年04月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, supervisors, and executives, with specific numbers of shares held, pledged shares, and related percentages. It focuses on insider shareholdings and their changes, which is typical of a Director's Dealing or insider share transaction report. There is no indication of financial statements, earnings data, or meeting materials. The document length is 3815 characters, which is relatively short but contains detailed insider shareholding data. Therefore, the document is best classified as a Director's Dealing report.
2018-05-08 Chinese
107年04月法人說明會簡報 — 414220180409E001.pdf
Investor Presentation Classification · 95% confidence The document is a detailed presentation about a vaccine manufacturing company, including its history, product lines, certifications, international marketing, GMP audits, and strategic partnerships. It contains no financial statements, earnings data, or regulatory filings. The content is focused on business overview, technology, product development, market positioning, and company strategy. The length is over 11,000 characters, indicating a substantial document rather than a brief announcement. The nature of the content aligns with an Investor Presentation, which typically includes company background, product portfolio, market strategy, and competitive positioning for investors. There is no indication that this is an Annual Report, Earnings Release, or any regulatory filing. Therefore, the most appropriate classification is Investor Presentation (IP).
2018-04-10 Chinese
107年04月法人說明會簡報 — 414220180409M001.pdf
Investor Presentation Classification · 95% confidence The document is a detailed presentation about the company's business outlook, product lines, market positioning, certifications, and strategic partnerships. It includes extensive information on the company's operations, technology, product diversification, international market presence, and GMP certifications. There are no indications that this is a formal financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a regulatory filing or announcement of voting results. The content is structured as a corporate presentation aimed at investors or stakeholders to provide an overview of the company's business and strategic direction. Therefore, the document best fits the category of an Investor Presentation (IP). The document length (11,866 characters) and detailed content support this classification with high confidence.
2018-04-10 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.